Introduction {#Sec1}
============

Nephrotic syndrome (NS) is the most common glomerular disorder of childhood. It is defined by proteinuria, hypoalbuminaemia, oedema and hyperlipidaemia \[[@CR1]\]. Most (80%) children have a minimal-change NS (MCNS). Other diagnoses, which could be the cause of NS, are focal segmental glomerulosclerosis (FSGS), congenital NS (CNS) and NS due to glomerulonephritis or other glomerulopathies. Although NS is relatively rare, it accounts for mortality and considerable morbidity in young children. The prognosis of NS in children correlates with the spectrum of responsiveness to steroid therapy, from steroid-sensitive NS (SSNS) to steroid-resistant NS (SRNS). SRNS is the most common acquired cause of end-stage renal disease (ESRD) in children \[[@CR2]\]. The aim of this study was to determine the incidence of NS in The Netherlands. All new cases of NS in The Netherlands of children 0--18 years of age were prospectively registered from 1 January 2003 till 1 January 2007. The second aim was to compare these results with the incidences of NS described in the literature.

Methods {#Sec2}
=======

Literature search {#Sec3}
-----------------

A literature search was done in February 2009. We searched for articles in PubMed and Embase. Relevant thesaurus terms and/or free-text terms for NS, epidemiology, cohort, retrospective and prospective study types were used. The searches were limited to the age group of 0--18 years and articles written in English, French, German, Dutch or Arabic. Inclusion criteria were all studies on NS that describe the incidence or epidemiology of NS in children 0--18 years in a nationwide or a hospital population.

Study design {#Sec4}
------------

The registry was started by the working group Idiopathic Nephrotic Syndrome, which consists of all paediatric nephrologists in The Netherlands in collaboration with the Dutch Pediatric Surveillance Unit hosted by The Netherlands Institute of Applied Science \[Nederlands Signalerings Centrum Kindergeneeskunde (NSCK) at TNO, Leiden\]. The NSCK is a voluntary national registry used by paediatricians to report various rare or new paediatric disorders and is one of 13 paediatric surveillance units in the world. Our study includes all children with newly diagnosed NS between 1 January 2003 and 1 January 2007. The case definition was any child \<18 years with symptoms of NS defined as oedema, proteinuria (\> 3 + on a dipstick), low serum albumin (\<25 g/l) and normal renal function (serum creatinine in normal range for age when not volume depleted), without signs of systemic disease or macroscopic haematuria. The study was conducted in The Netherlands. All paediatricians in The Netherlands received a monthly blue card or Web link to an electronic card and were asked to return the card to the NSCK if they had a patient with a newly diagnosed NS. A questionnaire was sent to the registering paediatrician, which had to be returned to the Idiopathic Nephrotic Syndrome Working Group at the VU University Medical Center, where data were analyzed. When the questionnaires were incomplete, secondary phone calls and visits were carried out to try to complete them as far as possible. The coded questionnaires showed only initials, birth date and a part of the postal code. Medical ethical approval was thought not to be necessary due to the anonymous submission of the questionnaires. Informed consent forms were filled in by the parents of the patients. The number of responding paediatricians working in The Netherlands in 2003--2006 was 694 (mean) divided over 96 paediatric practices and eight university centres with a paediatric nephrology department.

Statistical analysis {#Sec5}
--------------------

The incidence of NS was calculated by relating the number of de novo NS patients to the number of children \<18 years who were living during the 4 years of registration in the several provinces separately and in The Netherlands as a whole. The population numbers were extracted from the official statistics organ (Statistics Netherlands). These data can be found on the Web site and are freely available. Male:female ratio and median and mean age of the affected children were calculated from the available data. Pearson's chi-square test was used to compare the incidences of the years and the provinces. A *p* value \<0.05 was considered to be significant.

Results {#Sec6}
=======

Literature review {#Sec7}
-----------------

We found 504 abstracts from PubMed and 214 abstracts from Embase; 669 abstracts were left after removing duplicates. Thirty-one appeared to fulfil the inclusion criteria, but after reading the full articles, only nine fulfilled all inclusion criteria. We found three more abstracts (personal enquiry) that were not found in the systematic search. Hodson et al. \[[@CR3]\] published the results of a national registry of children with NS in Australia in the annual report of the Australian Paediatric Surveillance Unit, and Bouissou et al. presented a poster about the epidemiology of NS in two French regions at the European Society of Paediatric Nephrology Congress of 1993. Ultimately, nine retrospective and three prospective studies met all inclusion criteria (Table [1](#Tab1){ref-type="table"}). Table 1Results of the literature review on incidences of neprhrotic syndrome (NS) in childhoodSourceStudy periodCountry (area)Number of patientsMale:femaleAgeIncidence (per 100,000/year)**Retrospective studies**Elzouki et al. \[[@CR5]\]1968-1982Benghazi, Libya1341.3:112 weeks-14 years11.6Mean 5.7 (1.5-13)Feehally et al. \[[@CR6]\]1973-1982Leicestershire, UK43Asian 2.0:1\< 15 years2.3Mean ageNon-Asian 1.4:1Asian 4,2Asians 9.4N-Asian 4.3Non-Asians 1.3McKinney et al. \[[@CR7]\]1 Jan 1987--31 Dec 1998Former Yorkshire Regional Health Authority, UK1941.6:10-15 years2.3Median SSNS 4.5SRNS 6Schlesinger et al. \[[@CR8]\]1946- 1961Erie county, USA861.96:1\< 16 years2.0Sharples et al. \[[@CR9]\]1 Jan 1979-- 31 Dec 1983Birmingham, UK441.8:1\< 16 years5.3Mean ageAsian 16.9Asian 3.4European 2.6European 4.2Afro-Caribbean 3.4Srivastata et al. \[[@CR10]\]1984-1995Metropolitan area of Kansas City, USAGroup A 148Group A 1.5:11-16 yearsGroup B primary NS 2.2Group A mean 6.6Median 5.0Caucasian 1.8Group B 86Group B 1.46:1Group BAfrican American 3.6Mean 7.38Median 5.0Wyatt et al. \[[@CR11]\]1970-1979Eastern part of Kentucky, USA342.09:11-10 years1.8Zaki et al. \[[@CR12]\]1981-1985Farwaniya and Jahra, Kuwait551.75:1\< 12 years7.2 (\< 10 years)Mean age 5.36.0 (\< 12 years)Rothenberg et al. \[[@CR13]\]1949-1953Cleveland, Ohio, USAOhio 1721.07:10-9 yearsOhio 2.3Greater Cleveland 54Greater Cleveland 6.9**Prospective studies**Wong et al. \[[@CR14]\]1 Jul 2001--1 Jul 2004New Zealand492.5:13 months- 15 years1.9Mean 6.1Median 4.9Hodson et al. \[[@CR3]\]Jul 1998- Dec 2000Australia1351.21: 13 months −15 years1.15Bouissou et al. (ESPN 1993)1985-1992Midi-Pyrenees and Auvergne, FranceNA1.57:11-15 years2.1El Bakkali et al. (this study)2003-2006The Netherlands2312.04:10-18 years1.52Median 3.88Mean 5.08*SSNS* steroid-sensitive NS, *SRNS* steroid-resistant NS, *NA* not available, *ESPN* European Society of Paediatric Nephrology

Registry {#Sec8}
--------

Between January 2003 and December 2006, 300 children were reported. Initially, the response rate of NSCK was 92.8% (mean of the years 2003--2006) \[[@CR4]\], but after first and second reminders and active inquiries, the response rate increased to 96.7%. Of the 300 questionnaires, 69 did not meet the inclusion criteria due to the fact that some patients did not have a newly diagnosed NS during the period of registration (7.3%) but had a relapse, and other patients were registered as NS but had another illness (6.0%). There were 4.3% duplicate questionnaires. Seven patients (2.3%) were diagnosed abroad with NS: six in The Netherlands Antilles (one on Saint Martin and five on Curaçao), and another in India (this child was later adopted to The Netherlands). These patients were not included in the Dutch incidence for that particular year. During the period of enquiry, five (1.7%) medical charts could not be found. Finally, four patients (1.3%) with CNS were excluded. Ultimately, 231 patients (77.0%) met the inclusion criteria.

The calculated annual incidence of NS in The Netherlands in 2003--2006 was 1.52 per 100,000 living children per year. The incidence for each year ranged from 1.32 to 1.77 per 100,000 children per year. The annual incidences did not differ significantly. The distribution of patients in The Netherlands with its 12 provinces is shown in Fig. [1](#Fig1){ref-type="fig"}. This is a chart of the place of residence of all registered patients. There was no statistically significant difference in distrubution within the provinces. This was also corrected for population density in each province. Fig. 1Distribution of patients with a newly diagnosed nephrotic syndrome in The Netherlands during 2003--2006

The Dutch cohort counted 76 girls and 155 boys with newly diagnosed NS. There was a significant difference between the numbers of boys versus girls (*p* = 0.0005). Median age was 3.88 years at admission (mean 5.08 years). One child was younger than 12 months and older than 3 months. One patient died within a few weeks after diagnosis as a result of sepsis and disseminated intravascular coagulation. The mortality rate was 1 of 231 patients (0.43%) during the first 5 weeks after presentation.

Discussion {#Sec9}
==========

The articles found in the literature review relate mostly to retrospective studies from around the world (Table [1](#Tab1){ref-type="table"}). They describe different populations, backgrounds and a large variability in genetics. All these factors influence the comparability.

Historic retrospective study dates are reported from 1946 onwards (Erie County, OH, USA) till 1998 (Yorkshire, UK) \[[@CR5]--[@CR13]\]. From the three prospective studies, one was from France (1985--1992) (Bouissou et al. ESPN 1993) and the other two from New Zealand and Australia in 1998--2004 (Table [1](#Tab1){ref-type="table"}) \[[@CR3], [@CR14]\]. The retrospective articles merely studied a hospital population or part of the population in a city, region, county or several districts. Thus, results from a wide variety of populations make them difficult to compare. A retrospective incidence in different age groups was reported as 1.8--11.6:100,000 patients/year \[[@CR5]--[@CR13]\]. The two more recent prospective population studies in New Zealand and Australia were quite similar to the one in The Netherlands, and they also used the Paediatric Surveillance Unit to register all new cases of NS \[[@CR3], [@CR14]\]. To our knowledge, the Dutch study is the largest and longest prospective study so far.

We registered all children with NS in The Netherlands for 4 years. The NSCK shows a response rate of 92.75% \[[@CR4]\]. Beyond that, we extensively explored possible nonregistered cases by regular announcements, personal telephone calls and e-mail contacts with nearly all Dutch paediatricians. We believe that we have registered all children with newly diagnosed NS in The Netherlands, so defining a reliable incidence. The three prospective studies revealed an incidence of 1.15--2.1 per 100,000 \[[@CR3], [@CR14]\] children per year, which was comparable with the Dutch incidence of 1.52 per 100,000 children per year in 2003--2006. In contrast to the studies in Australia \[[@CR3]\] and France (Bouissou et al, ESPN 1993), our Dutch population showed a higher male preponderance, whereas the study in New Zealand \[[@CR13]\] showed an even higher male:female ratio (2.5:1). In comparison with the retrospective studies the male:female ratio of 2.04:1 is similar to the ones found in the study by Schlesinger et al. in Erie County, OH, \[[@CR8]\] and Wyatt et al. in the eastern part of Kentucky in the United States \[[@CR11]\]. The other studies show a lower male:female ratio \[[@CR5]--[@CR7], [@CR9], [@CR10], [@CR12], [@CR13]\]. Even if the older children (\>15 years) were left out, compared with the registration in Australia \[[@CR14]\], this predominance still existed. In the general population in The Netherlands, the male:female ratio is 1.05:1, and in Australia this ratio is also 1.05:1; thus, this does not explain the difference between the two countries. Wong et al. do not explain why they think that the ratio found in their study differs from the rest of the studies \[[@CR14]\]. We do not have a thorough explanation for the difference in male:female ratio between the studies. Boyer et al. \[[@CR15]\] described that patients with FSGS were older at diagnosis and that the female gender was slightly overrepresented in comparison with children with another aetiology of NS. In our study, the male predominance was present in nearly all age groups.

The definition of NS was similar in all studies in relation to symptoms and laboratory findings. However, the inclusion criteria of ethnic background and age were not comparable. Our registry included all children aged from 0 to 18 years. After we completed the database, children with congenital NS were excluded because of the difference in pathogenesis. During the 4 years of registration, four children with congenital NS were excluded. According to this registration, the incidence of CNS in The Netherlands was one child with CNS per year. Exclusion of CNS is the reason that some studies started registration from 3 months onwards.

Wong et al. \[[@CR13]\], Srivastata et al. \[[@CR10]\] and McKinney et al. \[[@CR7]\] reported a median age of, respectively, 4.5, 5.0, 4.5 (SSNS) and 6.0 (SRNS) years; mean age differed from 3.4 to 7.4 years \[[@CR7], [@CR10], [@CR13]\]. Some studies did not mention a median or mean age. The median age found in our study was 3.9 years and is lower than the ones found in the reviewed literature, where mean age appeared to be 5.1 years. Due to the fact that some ethnic groups seem to be more prone to developing FSGS (e.g. African American and Indian children) rather than MCNS \[[@CR16]\], retrospective studies might be biased, because they are mostly based on medical charts in one centre or region of a country. In our prospective study, a question about the ethnic background was not included. Ethnicity will be explored in a follow-up study planned to begin soon. Some paediatricians spontaneously mentioned the ethnicity of their patient in the questionnaire. For 32 patients, ethnicity is not known (14%). With the gathered information in the questionnaires so far and the informed consent forms, we were able to divide the rest of the patients into Western and non-Western ethnic group. The majority of patients (60.1%) were of Dutch nationality (from western origin). The non-Western patients (25.9%) came from a wide variety of countries divided over all continents.

The mortality rate in this study is preliminary because it only shows the number of patients who died at presentation. To our knowledge, other series do not report mortality at presentation. This means that NS is still a serious disease, even at presentation. Two other authors published mortality rates, but all in earlier years, and were not comparable with idiopathic NS as stated in the definition \[[@CR8], [@CR13]\].

In conclusion, our study showed an incidence in the same range as the few other prospective studies. Idiopathic NS in children in the Dutch population is as much a rare disease as in any other country in the world. We found a statistically significant male:female ratio in this study, which is not fully explained but is in line with one other prospective study that described a similar or even higher male:female ratio in their cohort. Given the rarity of the disease and the lack of understanding of the exact pathogenesis of NS in children, more research is needed, preferably done in international collaboration studies.
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